Antimicrobial Formulations - Global and China Top Players Market Share and Ranking 2023
According to Latest Research, the global market for Antimicrobial Formulations should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Antimicrobial Formulations market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Antimicrobial Formulations market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Antibacterial Drug grew percent to account for percent of the total market sales, and Antifungal Drug grew percent.
Components of an agent that kills microorganisms or stops their growth.
This report studies and analyses global Antimicrobial Formulations status and future trends, helps the client to determine the Antimicrobial Formulations market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Antimicrobial Formulations, and provides market size (in Kilograms & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Antimicrobial Formulations market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (Kilograms)
(2) Global Antimicrobial Formulations sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Kilograms)
(3) China Antimicrobial Formulations sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (Kilograms)
(4) Global Antimicrobial Formulations key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Antimicrobial Formulations key producing regions, capacity, production, and year over year growth
(6) Antimicrobial Formulations industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Pfizer
GlaxoSmithKline
Finecure Pharmaceuticals Limited
Centrient Pharmaceuticals
Otsuka Pharmaceutical Factory
Foster Corporation
Hindustan Antibiotics Limited
Sandoz International GmbH
Stepan Company
Ciron Drugs
API Co. Ltd
Nabriva Therapeutics
Lonza
Microban
Hanmi Pharm.Co.,Ltd.
Market segment by Type, covers
Triclosan
Triclocarban
Parabens
Market segment by Application, can be divided into
Antibacterial Drug
Antifungal Drug
Antiviral Agent
Antiparasitic drug
Others
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Antimicrobial Formulations product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Antimicrobial Formulations market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Antimicrobial Formulations market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Antimicrobial Formulations, percent & CAGR, 2018-2029
Chapter 5: Antimicrobial Formulations industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Antimicrobial Formulations Definition
1.2 Global Antimicrobial Formulations Market Size and Forecast
1.2.1 By Consumption Value, Global Antimicrobial Formulations Market Size，2018-2029
1.2.2 By Sales Quantity, Global Antimicrobial Formulations Market Size，2018-2029
1.2.3 Global Antimicrobial Formulations Average Selling Price (ASP)，2018-2029
1.3 China Antimicrobial Formulations Market Size and Forecast
1.3.1 By Consumption Value, China Antimicrobial Formulations Market Size，2018-2029
1.3.2 By Sales Quantity, China Antimicrobial Formulations Market Size，2018-2029
1.3.3 China Antimicrobial Formulations Average Selling Price (ASP)， 2018-2029
1.4 Share of China Antimicrobial Formulations Market with Respect to the Global Market
1.4.1 By Consumption Value, China Antimicrobial Formulations Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Antimicrobial Formulations Market Share in Global, 2018-2029
1.4.3 Antimicrobial Formulations Market Size: China VS Global, 2018-2029
1.5 Antimicrobial Formulations Market Dynamics
1.5.1 Antimicrobial Formulations Market Drivers
1.5.2 Antimicrobial Formulations Market Restraints
1.5.3 Antimicrobial Formulations Industry Trends
1.5.4 Antimicrobial Formulations Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Antimicrobial Formulations, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Antimicrobial Formulations, Global Market Share by Company, 2018-2023
2.3 Antimicrobial Formulations Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Antimicrobial Formulations Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Antimicrobial Formulations Concentration Ratio
2.6 Global Antimicrobial Formulations Mergers & Acquisitions, Expansion Plans
2.7 Global Antimicrobial Formulations Manufacturers Product Type
2.8 Head Office and Antimicrobial Formulations Production Site of Key Manufacturer
2.9 Antimicrobial Formulations Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Antimicrobial Formulations, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Antimicrobial Formulations, China Market Share by Company, 2018-2023
3.3 China Antimicrobial Formulations Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Antimicrobial Formulations Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Antimicrobial Formulations Capacity by Region
4.3 Global Antimicrobial Formulations Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Antimicrobial Formulations Production by Region, 2018-2029
4.5 Global Antimicrobial Formulations Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Antimicrobial Formulations Industry Chain
5.2 Antimicrobial Formulations Upstream Analysis
5.2.1 Antimicrobial Formulations Core Raw Materials
5.2.2 Main Manufacturers of Antimicrobial Formulations Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Antimicrobial Formulations Production Mode
5.6 Antimicrobial Formulations Procurement Model
5.7 Antimicrobial Formulations Industry Sales Model and Sales Channels
5.7.1 Antimicrobial Formulations Sales Model
5.7.2 Antimicrobial Formulations Typical Distributors
6 Sights by Type
6.1 Antimicrobial Formulations Classification
6.1.1 Triclosan
6.1.2 Triclocarban
6.1.3 Parabens
6.2 By Type, Global Antimicrobial Formulations Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Antimicrobial Formulations Consumption Value, 2018-2029
6.4 By Type, Global Antimicrobial Formulations Sales Quantity, 2018-2029
6.5 By Type, Global Antimicrobial Formulations Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Antimicrobial Formulations Segment by Application
7.1.1 Antibacterial Drug
7.1.2 Antifungal Drug
7.1.3 Antiviral Agent
7.1.4 Antiparasitic drug
7.1.5 Others
7.2 By Application, Global Antimicrobial Formulations Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Antimicrobial Formulations Consumption Value, 2018-2029
7.4 By Application, Global Antimicrobial Formulations Sales Quantity, 2018-2029
7.5 By Application, Global Antimicrobial Formulations Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Antimicrobial Formulations Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Antimicrobial Formulations Consumption Value, 2018-2029
8.3 By Region, Global Antimicrobial Formulations Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Antimicrobial Formulations & Forecasts, 2018-2029
8.4.2 By Country, North America Antimicrobial Formulations Market Size Market Share
8.5 Europe
8.5.1 Europe Antimicrobial Formulations Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Antimicrobial Formulations Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Antimicrobial Formulations Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Antimicrobial Formulations Market Size Market Share
8.7 South America
8.7.1 South America Antimicrobial Formulations Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Antimicrobial Formulations Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Antimicrobial Formulations Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Antimicrobial Formulations Consumption Value, 2018-2029
9.3 By Country, Global Antimicrobial Formulations Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Antimicrobial Formulations Market Size, 2018-2029
9.4.2 By Type, U.S. Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Antimicrobial Formulations Market Size, 2018-2029
9.5.2 By Type, Europe Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Antimicrobial Formulations Market Size, 2018-2029
9.6.2 By Type, China Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Antimicrobial Formulations Market Size, 2018-2029
9.7.2 By Type, Japan Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Antimicrobial Formulations Market Size, 2018-2029
9.8.2 By Type, South Korea Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Antimicrobial Formulations Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Antimicrobial Formulations Market Size, 2018-2029
9.10.2 By Type, India Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Antimicrobial Formulations Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Pfizer
10.1.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
10.1.2 Pfizer Antimicrobial Formulations Models, Specifications, and Application
10.1.3 Pfizer Antimicrobial Formulations Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Pfizer Company Profile and Main Business
10.1.5 Pfizer Recent Developments
10.2 GlaxoSmithKline
10.2.1 GlaxoSmithKline Company Information, Head Office, Market Area, and Industry Position
10.2.2 GlaxoSmithKline Antimicrobial Formulations Models, Specifications, and Application
10.2.3 GlaxoSmithKline Antimicrobial Formulations Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 GlaxoSmithKline Company Profile and Main Business
10.2.5 GlaxoSmithKline Recent Developments
10.3 Finecure Pharmaceuticals Limited
10.3.1 Finecure Pharmaceuticals Limited Company Information, Head Office, Market Area, and Industry Position
10.3.2 Finecure Pharmaceuticals Limited Antimicrobial Formulations Models, Specifications, and Application
10.3.3 Finecure Pharmaceuticals Limited Antimicrobial Formulations Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Finecure Pharmaceuticals Limited Company Profile and Main Business
10.3.5 Finecure Pharmaceuticals Limited Recent Developments
10.4 Centrient Pharmaceuticals
10.4.1 Centrient Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
10.4.2 Centrient Pharmaceuticals Antimicrobial Formulations Models, Specifications, and Application
10.4.3 Centrient Pharmaceuticals Antimicrobial Formulations Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Centrient Pharmaceuticals Company Profile and Main Business
10.4.5 Centrient Pharmaceuticals Recent Developments
10.5 Otsuka Pharmaceutical Factory
10.5.1 Otsuka Pharmaceutical Factory Company Information, Head Office, Market Area, and Industry Position
10.5.2 Otsuka Pharmaceutical Factory Antimicrobial Formulations Models, Specifications, and Application
10.5.3 Otsuka Pharmaceutical Factory Antimicrobial Formulations Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Otsuka Pharmaceutical Factory Company Profile and Main Business
10.5.5 Otsuka Pharmaceutical Factory Recent Developments
10.6 Foster Corporation
10.6.1 Foster Corporation Company Information, Head Office, Market Area, and Industry Position
10.6.2 Foster Corporation Antimicrobial Formulations Models, Specifications, and Application
10.6.3 Foster Corporation Antimicrobial Formulations Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Foster Corporation Company Profile and Main Business
10.6.5 Foster Corporation Recent Developments
10.7 Hindustan Antibiotics Limited
10.7.1 Hindustan Antibiotics Limited Company Information, Head Office, Market Area, and Industry Position
10.7.2 Hindustan Antibiotics Limited Antimicrobial Formulations Models, Specifications, and Application
10.7.3 Hindustan Antibiotics Limited Antimicrobial Formulations Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Hindustan Antibiotics Limited Company Profile and Main Business
10.7.5 Hindustan Antibiotics Limited Recent Developments
10.8 Sandoz International GmbH
10.8.1 Sandoz International GmbH Company Information, Head Office, Market Area, and Industry Position
10.8.2 Sandoz International GmbH Antimicrobial Formulations Models, Specifications, and Application
10.8.3 Sandoz International GmbH Antimicrobial Formulations Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Sandoz International GmbH Company Profile and Main Business
10.8.5 Sandoz International GmbH Recent Developments
10.9 Stepan Company
10.9.1 Stepan Company Company Information, Head Office, Market Area, and Industry Position
10.9.2 Stepan Company Antimicrobial Formulations Models, Specifications, and Application
10.9.3 Stepan Company Antimicrobial Formulations Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Stepan Company Company Profile and Main Business
10.9.5 Stepan Company Recent Developments
10.10 Ciron Drugs
10.10.1 Ciron Drugs Company Information, Head Office, Market Area, and Industry Position
10.10.2 Ciron Drugs Antimicrobial Formulations Models, Specifications, and Application
10.10.3 Ciron Drugs Antimicrobial Formulations Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Ciron Drugs Company Profile and Main Business
10.10.5 Ciron Drugs Recent Developments
10.11 API Co. Ltd
10.11.1 API Co. Ltd Company Information, Head Office, Market Area, and Industry Position
10.11.2 API Co. Ltd Antimicrobial Formulations Models, Specifications, and Application
10.11.3 API Co. Ltd Antimicrobial Formulations Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 API Co. Ltd Company Profile and Main Business
10.11.5 API Co. Ltd Recent Developments
10.12 Nabriva Therapeutics
10.12.1 Nabriva Therapeutics Company Information, Head Office, Market Area, and Industry Position
10.12.2 Nabriva Therapeutics Antimicrobial Formulations Models, Specifications, and Application
10.12.3 Nabriva Therapeutics Antimicrobial Formulations Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Nabriva Therapeutics Company Profile and Main Business
10.12.5 Nabriva Therapeutics Recent Developments
10.13 Lonza
10.13.1 Lonza Company Information, Head Office, Market Area, and Industry Position
10.13.2 Lonza Antimicrobial Formulations Models, Specifications, and Application
10.13.3 Lonza Antimicrobial Formulations Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Lonza Company Profile and Main Business
10.13.5 Lonza Recent Developments
10.14 Microban
10.14.1 Microban Company Information, Head Office, Market Area, and Industry Position
10.14.2 Microban Antimicrobial Formulations Models, Specifications, and Application
10.14.3 Microban Antimicrobial Formulations Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Microban Company Profile and Main Business
10.14.5 Microban Recent Developments
10.15 Hanmi Pharm.Co.,Ltd.
10.15.1 Hanmi Pharm.Co.,Ltd. Company Information, Head Office, Market Area, and Industry Position
10.15.2 Hanmi Pharm.Co.,Ltd. Antimicrobial Formulations Models, Specifications, and Application
10.15.3 Hanmi Pharm.Co.,Ltd. Antimicrobial Formulations Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Hanmi Pharm.Co.,Ltd. Company Profile and Main Business
10.15.5 Hanmi Pharm.Co.,Ltd. Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Antimicrobial Formulations Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Antimicrobial Formulations Market Restraints
Table 3. Antimicrobial Formulations Market Trends
Table 4. Antimicrobial Formulations Industry Policy
Table 5. Global Antimicrobial Formulations Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Antimicrobial Formulations Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Antimicrobial Formulations Sales Quantity by Company, (2018-2023) & (Kilograms), Ranked Based on Sales in 2022
Table 8. Global Antimicrobial Formulations Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Antimicrobial Formulations Average Selling Price (ASP) by Company, (2018-2023) & (US$/Kilogram)
Table 10. Global Antimicrobial Formulations Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Antimicrobial Formulations Mergers & Acquisitions, Expansion Plans
Table 12. Global Antimicrobial Formulations Manufacturers Product Type
Table 13. Head Office and Antimicrobial Formulations Production Site of Key Manufacturer
Table 14. Antimicrobial Formulations Capacity of Major Manufacturers and Future Plan
Table 15. China Antimicrobial Formulations Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Antimicrobial Formulations Sales Quantity by Company, (2018-2023) & (Kilograms), Ranked Based on Sales in 2022
Table 17. China Antimicrobial Formulations Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Antimicrobial Formulations Production & Forecast by Region, 2018 VS 2022 VS 2029, (Kilograms)
Table 19. Global Antimicrobial Formulations Production by Region, 2018-2023, (Kilograms)
Table 20. Global Antimicrobial Formulations Production Forecast by Region, 2024-2029, (Kilograms)
Table 21. Global Key Players of Antimicrobial Formulations Upstream (Raw Materials)
Table 22. Global Antimicrobial Formulations Typical Customers
Table 23. Antimicrobial Formulations Typical Distributors
Table 24. By Type, Global Antimicrobial Formulations Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Antimicrobial Formulations Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Antimicrobial Formulations Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Antimicrobial Formulations Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Antimicrobial Formulations Sales Quantity, 2018-2029, (Kilograms)
Table 29. By Country, Global Antimicrobial Formulations Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Antimicrobial Formulations Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Antimicrobial Formulations Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Antimicrobial Formulations Sales Quantity, 2018-2029, (Kilograms)
Table 33. By Country, Global Antimicrobial Formulations Sales Quantity Market Share, 2018-2029
Table 34. Pfizer Company Information, Head Office, Market Area, and Industry Position
Table 35. Pfizer Antimicrobial Formulations Models, Specifications, and Application
Table 36. Pfizer Antimicrobial Formulations Sales Quantity (Kilograms), Revenue (US$ Million), Price (US$/Kilogram) and Gross Margin, 2018-2023
Table 37. Pfizer Company Profile and Main Business
Table 38. Pfizer Recent Developments
Table 39. GlaxoSmithKline Company Information, Head Office, Market Area, and Industry Position
Table 40. GlaxoSmithKline Antimicrobial Formulations Models, Specifications, and Application
Table 41. GlaxoSmithKline Antimicrobial Formulations Sales Quantity (Kilograms), Revenue (US$ Million), Price (US$/Kilogram) and Gross Margin, 2018-2023
Table 42. GlaxoSmithKline Company Profile and Main Business
Table 43. GlaxoSmithKline Recent Developments
Table 44. Finecure Pharmaceuticals Limited Company Information, Head Office, Market Area, and Industry Position
Table 45. Finecure Pharmaceuticals Limited Antimicrobial Formulations Models, Specifications, and Application
Table 46. Finecure Pharmaceuticals Limited Antimicrobial Formulations Sales Quantity (Kilograms), Revenue (US$ Million), Price (US$/Kilogram) and Gross Margin, 2018-2023
Table 47. Finecure Pharmaceuticals Limited Company Profile and Main Business
Table 48. Finecure Pharmaceuticals Limited Recent Developments
Table 49. Centrient Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
Table 50. Centrient Pharmaceuticals Antimicrobial Formulations Models, Specifications, and Application
Table 51. Centrient Pharmaceuticals Antimicrobial Formulations Sales Quantity (Kilograms), Revenue (US$ Million), Price (US$/Kilogram) and Gross Margin, 2018-2023
Table 52. Centrient Pharmaceuticals Company Profile and Main Business
Table 53. Centrient Pharmaceuticals Recent Developments
Table 54. Otsuka Pharmaceutical Factory Company Information, Head Office, Market Area, and Industry Position
Table 55. Otsuka Pharmaceutical Factory Antimicrobial Formulations Models, Specifications, and Application
Table 56. Otsuka Pharmaceutical Factory Antimicrobial Formulations Sales Quantity (Kilograms), Revenue (US$ Million), Price (US$/Kilogram) and Gross Margin, 2018-2023
Table 57. Otsuka Pharmaceutical Factory Company Profile and Main Business
Table 58. Otsuka Pharmaceutical Factory Recent Developments
Table 59. Foster Corporation Company Information, Head Office, Market Area, and Industry Position
Table 60. Foster Corporation Antimicrobial Formulations Models, Specifications, and Application
Table 61. Foster Corporation Antimicrobial Formulations Sales Quantity (Kilograms), Revenue (US$ Million), Price (US$/Kilogram) and Gross Margin, 2018-2023
Table 62. Foster Corporation Company Profile and Main Business
Table 63. Foster Corporation Recent Developments
Table 64. Hindustan Antibiotics Limited Company Information, Head Office, Market Area, and Industry Position
Table 65. Hindustan Antibiotics Limited Antimicrobial Formulations Models, Specifications, and Application
Table 66. Hindustan Antibiotics Limited Antimicrobial Formulations Sales Quantity (Kilograms), Revenue (US$ Million), Price (US$/Kilogram) and Gross Margin, 2018-2023
Table 67. Hindustan Antibiotics Limited Company Profile and Main Business
Table 68. Hindustan Antibiotics Limited Recent Developments
Table 69. Sandoz International GmbH Company Information, Head Office, Market Area, and Industry Position
Table 70. Sandoz International GmbH Antimicrobial Formulations Models, Specifications, and Application
Table 71. Sandoz International GmbH Antimicrobial Formulations Sales Quantity (Kilograms), Revenue (US$ Million), Price (US$/Kilogram) and Gross Margin, 2018-2023
Table 72. Sandoz International GmbH Company Profile and Main Business
Table 73. Sandoz International GmbH Recent Developments
Table 74. Stepan Company Company Information, Head Office, Market Area, and Industry Position
Table 75. Stepan Company Antimicrobial Formulations Models, Specifications, and Application
Table 76. Stepan Company Antimicrobial Formulations Sales Quantity (Kilograms), Revenue (US$ Million), Price (US$/Kilogram) and Gross Margin, 2018-2023
Table 77. Stepan Company Company Profile and Main Business
Table 78. Stepan Company Recent Developments
Table 79. Ciron Drugs Company Information, Head Office, Market Area, and Industry Position
Table 80. Ciron Drugs Antimicrobial Formulations Models, Specifications, and Application
Table 81. Ciron Drugs Antimicrobial Formulations Sales Quantity (Kilograms), Revenue (US$ Million), Price (US$/Kilogram) and Gross Margin, 2018-2023
Table 82. Ciron Drugs Company Profile and Main Business
Table 83. Ciron Drugs Recent Developments
Table 84. API Co. Ltd Company Information, Head Office, Market Area, and Industry Position
Table 85. API Co. Ltd Antimicrobial Formulations Models, Specifications, and Application
Table 86. API Co. Ltd Antimicrobial Formulations Sales Quantity (Kilograms), Revenue (US$ Million), Price (US$/Kilogram) and Gross Margin, 2018-2023
Table 87. API Co. Ltd Company Profile and Main Business
Table 88. API Co. Ltd Recent Developments
Table 89. Nabriva Therapeutics Company Information, Head Office, Market Area, and Industry Position
Table 90. Nabriva Therapeutics Antimicrobial Formulations Models, Specifications, and Application
Table 91. Nabriva Therapeutics Antimicrobial Formulations Sales Quantity (Kilograms), Revenue (US$ Million), Price (US$/Kilogram) and Gross Margin, 2018-2023
Table 92. Nabriva Therapeutics Company Profile and Main Business
Table 93. Nabriva Therapeutics Recent Developments
Table 94. Lonza Company Information, Head Office, Market Area, and Industry Position
Table 95. Lonza Antimicrobial Formulations Models, Specifications, and Application
Table 96. Lonza Antimicrobial Formulations Sales Quantity (Kilograms), Revenue (US$ Million), Price (US$/Kilogram) and Gross Margin, 2018-2023
Table 97. Lonza Company Profile and Main Business
Table 98. Lonza Recent Developments
Table 99. Microban Company Information, Head Office, Market Area, and Industry Position
Table 100. Microban Antimicrobial Formulations Models, Specifications, and Application
Table 101. Microban Antimicrobial Formulations Sales Quantity (Kilograms), Revenue (US$ Million), Price (US$/Kilogram) and Gross Margin, 2018-2023
Table 102. Microban Company Profile and Main Business
Table 103. Microban Recent Developments
Table 104. Hanmi Pharm.Co.,Ltd. Company Information, Head Office, Market Area, and Industry Position
Table 105. Hanmi Pharm.Co.,Ltd. Antimicrobial Formulations Models, Specifications, and Application
Table 106. Hanmi Pharm.Co.,Ltd. Antimicrobial Formulations Sales Quantity (Kilograms), Revenue (US$ Million), Price (US$/Kilogram) and Gross Margin, 2018-2023
Table 107. Hanmi Pharm.Co.,Ltd. Company Profile and Main Business
Table 108. Hanmi Pharm.Co.,Ltd. Recent Developments
List of Figures
Figure 1. Antimicrobial Formulations Picture
Figure 2. Global Antimicrobial Formulations Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Antimicrobial Formulations Sales Quantity, (Kilograms) & (2018-2029)
Figure 4. Global Antimicrobial Formulations Average Selling Price (ASP), (2018-2029) & (US$/Kilogram)
Figure 5. China Antimicrobial Formulations Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Antimicrobial Formulations Sales Quantity (Kilograms) & (2018-2029)
Figure 7. China Antimicrobial Formulations Average Selling Price (ASP), (US$/Kilogram) & (2018-2029)
Figure 8. By Consumption Value, China Antimicrobial Formulations Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Antimicrobial Formulations Market Share of Global, 2018-2029
Figure 10. Global Antimicrobial Formulations Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Antimicrobial Formulations Key Participants, Market Share, 2022
Figure 12. Global Antimicrobial Formulations Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Antimicrobial Formulations Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Antimicrobial Formulations Production Market Share & Forecast by Region, 2018-2029
Figure 15. Antimicrobial Formulations Industry Chain
Figure 16. Antimicrobial Formulations Procurement Model
Figure 17. Antimicrobial Formulations Sales Model
Figure 18. Antimicrobial Formulations Sales Channels, Direct Sales, and Distribution
Figure 19. Triclosan
Figure 20. Triclocarban
Figure 21. Parabens
Figure 22. By Type, Global Antimicrobial Formulations Consumption Value, 2018-2029, US$ Million
Figure 23. By Type, Global Antimicrobial Formulations Consumption Value Market Share, 2018-2029
Figure 24. By Type, Global Antimicrobial Formulations Sales Quantity, 2018-2029, (Kilograms)
Figure 25. By Type, Global Antimicrobial Formulations Sales Quantity Market Share, 2018-2029
Figure 26. By Type, Global Antimicrobial Formulations Average Selling Price (ASP), 2018-2029, (US$/Kilogram)
Figure 27. Antibacterial Drug
Figure 28. Antifungal Drug
Figure 29. Antiviral Agent
Figure 30. Antiparasitic drug
Figure 31. Others
Figure 32. By Application, Global Antimicrobial Formulations Consumption Value, 2018-2029, US$ Million
Figure 33. By Application, Global Antimicrobial Formulations Consumption Value Market Share, 2018-2029
Figure 34. By Application, Global Antimicrobial Formulations Sales Quantity, 2018-2029, (Kilograms)
Figure 35. By Application, Global Antimicrobial Formulations Sales Quantity Market Share, 2018-2029
Figure 36. By Application, Global Antimicrobial Formulations Average Selling Price (ASP), 2018-2029, (US$/Kilogram)
Figure 37. By Region, Global Antimicrobial Formulations Consumption Value Market Share, 2018-2029
Figure 38. By Region, Global Antimicrobial Formulations Sales Quantity Market Share, 2018-2029
Figure 39. North America Antimicrobial Formulations Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, North America Antimicrobial Formulations Consumption Value Market Share, 2022
Figure 41. Europe Antimicrobial Formulations Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, Europe Antimicrobial Formulations Consumption Value Market Share, 2022
Figure 43. Asia Pacific Antimicrobial Formulations Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. By Country/Region, Asia Pacific Antimicrobial Formulations Consumption Value Market Share, 2022
Figure 45. South America Antimicrobial Formulations Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, South America Antimicrobial Formulations Consumption Value Market Share, 2022
Figure 47. Middle East & Africa Antimicrobial Formulations Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 48. U.S. Antimicrobial Formulations Sales Quantity, 2018-2029, (Kilograms)
Figure 49. By Type, U.S. Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, U.S. Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
Figure 51. Europe Antimicrobial Formulations Sales Quantity, 2018-2029, (Kilograms)
Figure 52. By Type, Europe Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, Europe Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
Figure 54. China Antimicrobial Formulations Sales Quantity, 2018-2029, (Kilograms)
Figure 55. By Type, China Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, China Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
Figure 57. Japan Antimicrobial Formulations Sales Quantity, 2018-2029, (Kilograms)
Figure 58. By Type, Japan Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, Japan Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
Figure 60. South Korea Antimicrobial Formulations Sales Quantity, 2018-2029, (Kilograms)
Figure 61. By Type, South Korea Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, South Korea Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
Figure 63. Southeast Asia Antimicrobial Formulations Sales Quantity, 2018-2029, (Kilograms)
Figure 64. By Type, Southeast Asia Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, Southeast Asia Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
Figure 66. India Antimicrobial Formulations Sales Quantity, 2018-2029, (Kilograms)
Figure 67. By Type, India Antimicrobial Formulations Sales Quantity Market Share, 2022 VS 2029
Fig
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|